Search for: "EAGLE PHARMACEUTICALS, INC."
Results 41 - 48
of 48
Sort by Relevance
|
Sort by Date
17 Aug 2009, 10:44 am
Tile, Inc. [read post]
26 Apr 2009, 5:10 pm
Eagle Pharmaceuticals Inc. 1:09-cv-00285; filed April 23, 2009 in the District Court of Delaware Infringement of U.S. [read post]
25 Jul 2008, 7:04 am
, (Daily Dose of IP), 26 August: WIPO symposium on IP and multilateral agreements – Geneva: (IPKat), 11-12 September: US LSI: 4th annual conference on ‘Current issues in complex IP licensing’ – Philadelphia: (Patent Docs), 11 September/15 October: PLI seminar on developments in pharmaceutical and biotech patent law – New York/San Francisco: (Patent Docs), 15-16 September: UniForum & SAIIPL domain name ADR workshop –… [read post]
11 Jul 2008, 4:30 am
, (Daily Dose of IP), 11-12 September: US LSI: 4th annual conference on ‘Current issues in complex IP licensing’ – Philadelphia: (Patent Docs), 11 September/15 October: PLI seminar on developments in pharmaceutical and biotech patent law – New York/San Francisco: (Patent Docs), 15-16 September: UniForum & SAIIPL domain name ADR workshop – Centurion (South Africa): (Afro-IP), 15-16 September: US ACI 10th advanced forum on biotech… [read post]
13 Jun 2008, 3:40 am
: (Patent Docs), Generic drug developers will continue to take advantage of global demand for lower-priced drugs, with Teva poised to maintain lead position says Goldman Sachs analyst: (GenericsWeb), Daiichi Sankyo takeover of Ranbaxy: (Profitability through Simplicity), (Spicy IP), (GenericsWeb), Canada: Generics to penetrate 26% pharma market in Canada says RNCOS research: (GenericsWeb), Canada: Generic drug makers spreading misinformation about patent regulation amendments to dodge real story:… [read post]
11 Feb 2008, 8:08 am
Amgen, Inc., No. 07-1999 "In an action against defendant charging fraudulent pricing of pharmaceutical drugs in violation of Wisconsin state law, an order remanding the case and sanctioning defendant is affirmed in part as to the remand order, but reversed as to the sanctions where: 1) the filing of a suit under the False Claims Act did not render this case removable; and 2) the paucity of appellate authority on the removability issue gave defendant a reasonable basis for… [read post]
7 Feb 2008, 10:46 am
Medtronic, Inc., 231 F.3d 216, 230 (6th Cir. 2001).Kemp concluded that the purported "violations" before it were not violations at all - but merely reflected Plaintiffs' incorrect reading of FDA requirements. [read post]
25 Jan 2007, 12:48 am
Ortho Pharmaceutical Corp., 661 N.E.2d 352, 355-56 (Ill. 1996). [read post]
